HCI
LIVE

Serial Number

97169341

Owner

HYBRID CONCEPTS INTERNATIONAL, LLC

Attorney

JOHN P. MURTAUGH

First Use Date

Jun 30, 2017

Filing Date

Dec 13, 2021

Add to watchlist:

No watchlists yet
View on USPTO

HCI Trademark

Serial Number: 97169341 • Registration: 7040282

HCI is a trademark filed by HYBRID CONCEPTS INTERNATIONAL, LLC on December 13, 2021. The trademark is classified under Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

HYBRID CONCEPTS INTERNATIONAL, LLC (3 trademarks)

2135 BEDELL ROAD, SUITE 9B
GRAND ISLAND, NY 14072

Entity Type: 16

Trademark Details

Filing Date

December 13, 2021

Registration Date

May 2, 2023

First Use Anywhere

June 30, 2017

First Use in Commerce

June 30, 2017

Published for Opposition

February 14, 2023

Goods & Services

Financial consulting services, namely, advising others regarding intellectual property investments; Investment consultation in the fields of product, technical, regulatory, preclinical, clinical, and commercial diligence for innovative potential or investigational medical products

Assistance, advisory services and consultancy with regard to business planning; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting services; Business consulting services in the field of potential medical cures including cell and gene therapies; Business consultation in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, chemistry, manufacturing and controls, and quality assurance/quality control; Business consulting services, namely, providing assistance in development of business strategies and creative ideation; Business management consulting and advisory services; Business support services, namely, business consulting to freelancers, start-ups, existing businesses and non-profit organizations; Consultancy and advisory services in the field of business strategy; Consulting services in the field of medical product approval for commercial purposes; International business consulting services relating to USA and outside of USA product, clinical and commercial development of investigational or approved medical products; New business venture development and formation consulting services; Promoting the exchange of information and resources within the scientific research communities to achieve advances in the field of 21st century transformational science; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Providing independent review of clinical trials for business purposes; Promoting technical and scientific investigation, research and experimentation in the field of scientific discovery through support of educational institutions and scientific organizations

Consulting services in the field of health; Consulting services to health care providers in the field of treating life-changing or life-threatening diseases

Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research information in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, manufacturing/CMC and quality assurance/quality control; Providing information about medical and scientific research; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific and technological services, namely, scientific research in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Scientific research consulting in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Scientific research and development; Technological planning and consulting services in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific consulting and research services relating to foods and dietary supplements; Scientific research consulting in the field of cosmetics

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 2, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
May 2, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 14, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 14, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 25, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 9, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 28, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 27, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 27, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 17, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 17, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 17, 2022 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 11, 2022 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 4, 2022 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2022 CNSA
ASSIGNED TO EXAMINER
Sep 19, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 16, 2021 NWOS
NEW APPLICATION ENTERED
Dec 16, 2021 NWAP